March 8, 2002, StockDiagnostics.com diagnoses D & K Healthcare with "The EPS Syndrome" (a negative accounting anomaly) which was discovered by our team. Enron was the impetus for our discovery of The EPS Syndrome, a not so rare disorder afflicting 19% of all non-financial U.S. public companies. D & K Healthcare (DKWD) shares close at a split adjusted $28.25.   August 14, 2002, D & K Healthcare forecasts record revenue and profits for its next 12 months. DKWD shares close @ $30.35.   August 19, 2002, StockDiagnostics.com in its OPS Newsletter warns that D & K Healthcare shares are at high risk, since it has been diagnosed with an accounting anomaly, "The EPS Syndrome" and its price "has yet to show significant decline". D & K Healthcare shares close at $27.42.   August 22, 2002. D & K Healthcare's shares decline to $24 and Wall Street analysts reiterate "buy" recommendations.   September 16, 2002; Approximately one month after it had announced its rosy projections, D & K Healthcare shares plummet from $24 to $8.58 when it announces that it expects its sales and profits to decline over the next 12 months. Back to case histories

Preview the D & K Healthcare OPS/EPS charts